Novartis AG (NVSEF)

USD 111.35

(6.92%)

Eps Summary of Novartis AG

  • Novartis AG's latest annual eps in 2023 was 7.63 USD , up 131.91% from previous year.
  • Novartis AG's latest quarterly eps in 2024 Q3 was 1.58 USD , down -1.86% from previous quarter.
  • Novartis AG reported an annual eps of 3.29 USD in 2022, down -69.34% from previous year.
  • Novartis AG reported an annual eps of 10.73 USD in 2021, up 185.37% from previous year.
  • Novartis AG reported a quarterly eps of 1.27 USD for 2024 Q1, down -70.87% from previous quarter.
  • Novartis AG reported a quarterly eps of 1.61 USD for 2024 Q2, up 26.77% from previous quarter.

Annual Eps Chart of Novartis AG (2023 - 1998)

Historical Annual Eps of Novartis AG (2023 - 1998)

Year Eps Eps Growth
2023 7.63 USD 131.91%
2022 3.29 USD -69.34%
2021 10.73 USD 185.37%
2020 3.76 USD 19.37%
2019 3.15 USD -42.1%
2018 5.44 USD 65.85%
2017 3.28 USD 16.31%
2016 2.82 USD -61.89%
2015 7.40 USD 75.77%
2014 4.21 USD 11.97%
2013 3.76 USD -4.33%
2012 3.93 USD 4.8%
2011 3.75 USD -12.38%
2010 4.28 USD 15.68%
2009 3.70 USD 2.21%
2008 3.62 USD -29.71%
2007 5.15 USD 68.3%
2006 3.06 USD 16.35%
2005 2.63 USD 15.35%
2004 2.28 USD 14.57%
2003 1.99 USD 5.85%
2002 1.88 USD 26.17%
2001 1.49 USD -12.35%
2000 1.70 USD 174.19%
1999 0.62 USD 87.88%
1998 0.33 USD 0.0%

Peer Eps Comparison of Novartis AG

Name Eps Eps Difference
AstraZeneca PLC 3.84 USD -98.698%
Bristol-Myers Squibb Company PFD CONV 2 3.88 USD -96.649%
CSPC Pharmaceutical Group Limited 0.07 USD -10800.0%
Clarus Therapeutics Holdings, Inc. -8.04 USD 194.9%
PT Kalbe Farma Tbk. 0.00 USD -195541.026%